0001209191-18-035717.txt : 20180605 0001209191-18-035717.hdr.sgml : 20180605 20180605163850 ACCESSION NUMBER: 0001209191-18-035717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180601 FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ULLIAN ELAINE CENTRAL INDEX KEY: 0001190290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18881647 MAIL ADDRESS: STREET 1: C/O HOLOGIC, INC. CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001190290 ULLIAN ELAINE C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2018-06-01 4 A 0 1801 0.00 A 12195 D Stock Option (Right to Buy) 152.74 2018-06-01 4 A 0 3229 0.00 A 2028-05-31 Common Stock 3229 3229 D Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Fully vested. /s/ Stephen Migausky, Attorney-in-Fact 2018-06-05